However, our finding extensively complemented Chemello et al. study by demonstrating the applicability of base editing strategy for robust dystrophin rescue in genetically humanized mdx models over a long-term (10-month) observation period with the systemic AAV-ABE delivery method that is also similarly required for disease intervention in DMD patients. This evidence concerns the gene DMD and Duchenne muscular dystrophy.